cladribine has been researched along with Agranulocytosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chao, Z; Chen, XM; Deng, CX; DU, X; Huang, X; Lai, PL; Li, MM; Liao, PJ; Ling, W; Lu, ZS; Wan, CC; Wang, YL; Weng, JY; Wu, SJ; Zhong, LY; Zou, XL | 1 |
| Burris, HA; Eckardt, JR; Fields, S; Kuhn, JG; Rizzo, J; Rodriguez, GI; Smith, LS; VanDenBerg, K; von Hoff, DD; Weiss, GR | 1 |
1 trial(s) available for cladribine and Agranulocytosis
| Article | Year |
|---|---|
A phase I and pharmacokinetics study of 2-chlorodeoxyadenosine in patients with solid tumors.
Topics: Adult; Aged; Agranulocytosis; Anemia; Cell Count; Chromatography, High Pressure Liquid; Cladribine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Humans; Infusions, Intravenous; Lymphopenia; Male; Middle Aged; Neoplasms; Neutrophils; Thrombocytopenia | 1995 |
1 other study(ies) available for cladribine and Agranulocytosis
| Article | Year |
|---|---|
[Effectiveness of CLAT Protocol for Treating Patients with Refractory Acute Myeloid Leukemia].
Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; Cladribine; Cytarabine; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction; Thrombocytopenia; Topotecan; Young Adult | 2016 |